Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US6285301072
Ticker MYL
Company MYLAN
Currency $
Price
Aware Investor Index (AII) 0.0275
Recommendation SELL
P/E 17.77
ROE 4.46 %
Capitalization 9,637,890,000 $
Dividend Yield 0.00 %
P/S 0.84
AII Position 556
P/E Position 226
ROE Position 639
Capitalization Position 477
Dividend Yield Position 594
Sales 11,433,900,000 $
10-Year Average Earnings 542,398,700 $
Shares Outstanding 516,500,000
Equity 12,167,100,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
MYLAN Investor Relations Web Site http://www.mylan.com/investors/public-filings







Sales:

YEAR MONTH AMOUNT
2018 12 11,433,900,000.00 $
2017 12 11,907,700,000.00 $
2016 12 11,076,900,000.00 $
2015 12 9,429,300,000.00 $
2014 12 7,719,600,000.00 $
2013 12 6,909,143,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 352,500,000.00 $
2017 12 696,000,000.00 $
2016 12 480,000,000.00 $
2015 12 847,600,000.00 $
2014 12 929,400,000.00 $
2013 12 623,711,000.00 $
2012 12 640,850,000.00 $
2011 12 536,810,000.00 $
2010 12 223,580,000.00 $
2009 12 93,536,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 12,167,100,000.00 $
2017 12 13,307,600,000.00 $
2016 12 11,117,600,000.00 $
2015 12 9,765,800,000.00 $
2014 12 3,276,000,000.00 $
2013 12 2,959,907,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 516,500,000
2017 12 536,700,000
2016 12 520,500,000
2015 12 497,400,000
2014 12 398,000,000
2013 12 394,454,000

 












Bloomberg News for MYLAN:



Google News for MYLAN:

Seeking Alpha - 4 days ago
Mylan: The EpiPen Shortage Could Sting
Patients and physicians are struggling to get access to on MYL's EpiPen. MYL's revenue and EBITDA are in decline. The rating agencies are ...
About Press Release (press release) - 12 hours ago
Is The Stock More Volatile Than The Market? :: Mylan NV, (NASDAQ ...
On Thursday, July 18, 2019, the USA's Company, Mylan N.V., MYL, (Loss, ↓) the Trending-Graph belongs to the sector of Healthcare.
The InvestReporter
Mylan NV (MYL) Target price is $29.53 as it is set for a tempting yields
Mylan N.V. (MYL) is presently priced at $17.91 after the most recent trading session. At the very opening of the session, the stock started at ...
The News Heater
As Mylan NV (MYL) Market Value Declined, Washington Capital ...
Washington Capital Management Inc increased its stake in Mylan N V (MYL) by 44.4% based on its latest 2019Q1 regulatory filing with the SEC ...
The MAK Daily
Mylan NV (MYL)'s Financial Results Comparing With CannTrust ...
Mylan N.V. (NASDAQ:MYL) and CannTrust Holdings Inc. (NYSE:CTST), are influenced by contrast since they are both players in the Drugs ...
The InvestChronicle - 1 day ago
EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce ...
It looks like there is no end is sight to the EpiPen shortage and Mylan (NASDAQ: MYL ) stock is taking a beating Wednesday on the news.
The InvestReporter - 1 day ago
What Can Investors Expect From Mylan NV (NASDAQ:MYL) Shares ...
91 were accumulated by Gemmer Asset Mngmt Limited Liability. Gulf Bank (Uk) Ltd has 0.06% invested in Mylan N.V. (NASDAQ:MYL) for ...
The InvestReporter - 22 hours ago
Career Education (CECO) Market Value Rose While Kenmare ...
Capstone Investment Advisors Llc decreased its stake in Mylan N V (MYL) by 69.76% based on its latest 2019Q1 regulatory filing with the SEC.
Nasdaq - 10 Jul 2019
Zoetis (ZTS) Position Held by Ardevora Asset Management Llp ...
Washington Capital Management Inc increased its stake in Mylan N V (MYL) by 44.4% based on its latest 2019Q1 regulatory filing with the SEC ...
Seeking Alpha
Mylan NV (MYL) vs. At Royal Gold, Inc. (RGLD): Industry's Two ...
The shares of Mylan N.V. have decreased by more than -34.85% this year alone. The shares recently went down by -0.34% or -$0.06 and now ...


Back